Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Healthcare Medical Devices
Theralase Technologies Inc. is a Canada-based clinical stage pharmaceutical company. The Company is engaged in the research and development of light, radiation, sound and/or drug-activated small molecule compounds, their associated drug formulations and the light systems that activate them, with a primary objective of efficacy and a secondary objective of safety in the destruction of various cancers, bacteria and viruses. It operates through two divisions: the Drug Division and the Device Division. The Drug Division is responsible for the research and development of light-activated small molecules primarily for the treatment of cancer with assistance from the Device Division to develop medical lasers to activate them. The Device Division is responsible for the Company’s medical laser business, which research, develops, manufactures and distributes cool laser therapy (CLT) systems to healthcare practitioners, predominantly for the healing of pain.


TSXV:TLT - Post by User

Theralase Technologies Inc. > We Sit and Wait
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(903)
•••
Comment by Oilminerdeluxeon Jan 21, 2025 2:29pm
180 Views
Post# 36413846

RE:RE:RE:RE:RE:RE:We Sit and Wait

RE:RE:RE:RE:RE:RE:We Sit and WaitEnd of February seems like a good possibility, if I read the tea leaves correctly.  No later than during Q1 seems to be the timeline right now. So Feb or March. As long as it gets done. If Dr. Lbiati has worked her magic, an official BTD approval should open doors after that. In a normal world at least. Perhaps the newsletter writers will be a bit more interested too. 

Does anyone have a clock on what number of treated patients fall into new categories? Any new ones reaching 450 days lately, or soon will?
<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities